0001543256-20-000001.txt : 20200226 0001543256-20-000001.hdr.sgml : 20200226 20200226115820 ACCESSION NUMBER: 0001543256-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 EFFECTIVENESS DATE: 20200226 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immunomic Therapeutics, Inc. CENTRAL INDEX KEY: 0001543256 IRS NUMBER: 203878827 STATE OF INCORPORATION: DE FISCAL YEAR END: 1212 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-361369 FILM NUMBER: 20654038 BUSINESS ADDRESS: STREET 1: ATTN: WILLIAM HEARL, 15010 BROSCHART RD. STREET 2: SUITE 250 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-728-0860 MAIL ADDRESS: STREET 1: ATTN: WILLIAM HEARL, 15010 BROSCHART RD. STREET 2: SUITE 250 CITY: ROCKVILLE STATE: MD ZIP: 20850 D 1 primary_doc.xml X0708 D LIVE 0001543256 Immunomic Therapeutics, Inc. ATTN: WILLIAM HEARL, 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 301-728-0860 DELAWARE None None Corporation true WILLIAM G. HEARL 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Executive Officer Director Chief Executive Officer and Director C. ERIC WINZER 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Executive Officer Director Chief Financial Officer and Director MICHAEL D. LACK 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director JAMES W. WISHART 15010 BROSCHART RD. SUITE 250 ROCKVILLE MD MARYLAND 20850 Director RONALD P. THIBOUTOT 15010 BROSCHART RD. SUITE 20850 ROCKVILLE MD MARYLAND 20850 Director Biotechnology Decline to Disclose 06b false 2020-02-18 true true true true false 0 60000000 10000000 50000000 false 1 400000 0 Remuneration includes warrants to purchase 80,000 shares at $5.00 per share. 0 false Immunomic Therapeutics, Inc. /s/ C. Eric Winzer C. Eric Winzer Chief Financial Officer 2020-02-26